Notably, exosomal lncRNA GAS5 holds the potential to be a reliable indicator for early detection of NSCLC, because it can distinguish stage I NSCLC patients from healthy individuals with an AUC of 0.822. This evidence concerns the gene GAS5 and non-small cell lung carcinoma.